Top Markets
#1 ADO Protocol ADO Protocol +195.93%
#2 Islamic Coin Islamic Coin +155.37%
#3 GoPlus Security GoPlus Security +59.90%
#4 Starpower Starpower +25.13%
#5 GAIB AID GAIB AID +24.67%
#6 The Black Bull The Black Bull +15.10%
#7 Casper Network Casper Network +14.54%
#8 Verus Coin Verus Coin +13.55%
#9 Status Status +12.46%
#10 o1.exchange o1.exchange +10.83%
Coin of the day
ADO Protocol ADO Protocol
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Anew Medical, Inc. Anew Medical, Inc.

Anew Medical, Inc.

WENA
Rang in aandelen #33467
Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing... Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing innovative treatments for conditions affecting the brain and nervous system, age-related illnesses, and specialized diagnostic tools. Their pipeline includes advanced cell and gene therapies specifically designed to alleviate symptoms of aging-related conditions, such as dementia, Alzheimer's disease, and various neuromuscular disorders. Additionally, Anew Medical is engaged in developing biologics and biosimilars for cancer treatment, alongside research into therapies targeting melanocortin receptors. A key strategic alliance exists with Japan's Okinawa Research Center, focusing on the collaborative research and development of Klotho gene therapy. This initiative aims to extend human longevity and diminish the impact of age-related diseases. The company maintains its headquarters in Omaha, Nebraska.
Aandeelprijs
$0.5099
Laatst gesynchroniseerd: 2024-10-15
Marktkapitalisatie
$7.60M
Verandering (1 dag)
2.02%
Verandering (1 jaar)
0.00%
Land
US
Handel Anew Medical, Inc. (WENA)

Categorie

Healthcare
P/B-ratio voor Anew Medical, Inc. (WENA)
P/B-ratio op August 2026 TTM: 0.63
Volgens de meest recente financiële rapporten en aandelenkoers van Anew Medical, Inc. is de huidige P/B-ratio (TTM) 0.63. Eind 2022 had het bedrijf een P/B-ratio van 0.79.
P/B-ratiohistoriek voor Anew Medical, Inc. van 2021 tot 2026
P/B-ratio aan het einde van elk jaar
Jaar P/B-ratio Wijzigen
2026 (TTM) 0.63 -87.86%
2023 5.20 561.31%
2022 0.79 -98.96%
2021 75.61 0.00%
P/B-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/B-ratio Verschil in P/B-ratio Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 904.26%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 888.33%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 448.09%
BE